Skip to main content
. 2025 Mar 5;15(3):373. doi: 10.3390/biom15030373
ACC American College of Cardiology
ADA American Diabetes Association
AHI Apnea–hypopnea index
AHA American Heart Association
ASCVD Atherosclerotic cardiovascular disease
ASMR Age-standardized mortality rate
BMD Bone mineral density
BMI Body mass index
BP Blood pressure
CAD Coronary artery disease
CVD Cardiovascular disease
CKD Chronic kidney disease
CRHM Cardiovascular–Renal–Hepatic–Metabolic syndrome
DASH Dietary approaches to stop hypertension
DPP4i Dipeptidyl peptidase-4 inhibitors
EAPC European Association of Preventive Cardiology
EASD European Association for the Study of Diabetes
EASO European Association for the Study of Obesity
ECG Electrocardiogram
ESC European Society of Cardiology
FHH Functional hypogonadotropic hypogonadism
GDMT Guideline-directed medical therapy
GIP Glucose-dependent insulinotropic polypeptide
GLP-1RA Glucagon-like peptide-1 receptor agonist
HbA1c Glycated hemoglobin
HF Heart failure
HFpEF Heart failure with preserved ejection fraction
HFrEF Heart failure with reduced ejection fraction
HIF-1α Hypoxia-inducible factor 1-alpha
HR Hazard ratio
IGF-I Insulin-like growth factor-I
LDL-C Low-density lipoprotein cholesterol
MASLD Metabolic dysfunction-associated steatotic liver disease
MHT Menopausal hormone therapy
MHDS Multiple hormonal and metabolic deficiency syndrome
NAFLD Non-alcoholic fatty liver disease
NASH Non-alcoholic steatohepatitis
NT-proBNP N-terminal prohormone of brain natriuretic peptide
OSA Obstructive sleep apnea
PAD Peripheral artery disease
PCOS Polycystic Ovary Syndrome
PCSK9 Proprotein convertase subtilisin/kexin type 9
PAP Positive airway pressure
POI Primary Ovarian Insufficiency
RCT Randomized controlled trial
RMR Resting metabolic rate
SGLT2i Sodium-glucose cotransporter-2 inhibitors
siRNA Small interfering RNA
T2DM Type 2 diabetes mellitus
TTh Testosterone therapy
TZD Thiazolidinedione
VO2 max Maximum oxygen consumption